−2.23USD
−93.80 MUSD
51.13 MUSD
28.51 M
About Repare Therapeutics Inc.
Sector
CEO
Lloyd M. Segal
Headquarters
Saint-Laurent
Website
Employees (FY)
179
Founded
2016
ISIN
US7602731025
FIGI
BBG00V5N3WP4
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RPTX is 3.04 USD — it has increased by 0.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Repare Therapeutics Inc. stocks are traded under the ticker RPTX.
Repare Therapeutics Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
RPTX stock is 1.80% volatile and has beta coefficient of 1.75. Check out the list of the most volatile stocks — is Repare Therapeutics Inc. there?
One year price forecast for Repare Therapeutics Inc. has a max estimate of 25.00 USD and a min estimate of 8.00 USD.
RPTX earnings for the last quarter are −0.45 USD per share, whereas the estimation was −0.86 USD resulting in a 47.60% surprise. The estimated earnings for the next quarter are −0.36 USD per share. See more details about Repare Therapeutics Inc. earnings.
Repare Therapeutics Inc. revenue for the last quarter amounts to 2.16 M USD despite the estimated figure of 6.31 M USD. In the next quarter revenue is expected to reach 18.93 M USD.
Yes, you can track Repare Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
RPTX stock has fallen by 21.65% compared to the previous week, the month change is a 42.10% fall, over the last year Repare Therapeutics Inc. has showed a 67.66% decrease.
RPTX net income for the last quarter is −28.03 M USD, while the quarter before that showed −18.88 M USD of net income which accounts for −48.47% change. Track more Repare Therapeutics Inc. financial stats to get the full picture.
Today Repare Therapeutics Inc. has the market capitalization of 127.39 M, it has decreased by 7.13% over the last week.
No, RPTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RPTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Repare Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 179.00 employees. See our rating of the largest employees — is Repare Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Repare Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Repare Therapeutics Inc. stock shows the sell signal. See more of Repare Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Repare Therapeutics Inc. future price: according to them, RPTX price has a max estimate of 25.00 USD and a min estimate of 8.00 USD. Read a more detailed Repare Therapeutics Inc. forecast: see what analysts think of Repare Therapeutics Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Repare Therapeutics Inc. EBITDA is −111.17 M USD, and current EBITDA margin is −220.62%. See more stats in Repare Therapeutics Inc. financial statements.